ECSP003721A - Una composicion farmaceutica para ser usada como anticonceptivo - Google Patents
Una composicion farmaceutica para ser usada como anticonceptivoInfo
- Publication number
- ECSP003721A ECSP003721A EC2000003721A ECSP003721A ECSP003721A EC SP003721 A ECSP003721 A EC SP003721A EC 2000003721 A EC2000003721 A EC 2000003721A EC SP003721 A ECSP003721 A EC SP003721A EC SP003721 A ECSP003721 A EC SP003721A
- Authority
- EC
- Ecuador
- Prior art keywords
- composition
- daily
- active agent
- dosage units
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La invención se relaciona con una composición farmacéutica que comprende con un primer agente activo, 6B, 7B; 15B, 16B dimetilen-3-oxo-17a pregn-4-en-21, 17-carbolactona (drospirenona) en una cantidad correspondiente a una dosis diaria, a ser administrada con la composición, de desde aproximadamente 2mg a aproximadamente 4mg, y, como un segundo agente activo, 17 a-etinilestradiol (etinilestradiol) en una cantidad correspondiente a una dosis diaria desde aproximadamente 0.01mg a aproximadamente 0,05mg conjuntamente con uno o mas soportes o excipientes farmacéuticamente aceptables. En una realización específica, la composición consiste de un número de unidades de dosificación diarias colocadas en una unidad de empauqe, empaquetadas separadamente y separables individualmente, y proporcionadas para la administarción oral durante un periodo de al menos 21 días consecutivos, comprendiendo dichas unidades de dosificación diaria la combinación de drospirenona y etilestradiol. La composición puede comprender admés 7 o menos unidades de dosificación diaria que no contienen agente activo o que contienen solo etinilestradiol.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99202826 | 1999-08-31 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP003721A true ECSP003721A (es) | 2002-05-23 |
Family
ID=8240592
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EC2000003721A ECSP003721A (es) | 1999-08-31 | 2000-10-18 | Una composicion farmaceutica para ser usada como anticonceptivo |
Country Status (6)
Country | Link |
---|---|
CN (1) | CN1879632A (es) |
AR (2) | AR025443A1 (es) |
CO (1) | CO5200771A1 (es) |
EC (1) | ECSP003721A (es) |
PE (1) | PE20010665A1 (es) |
ZA (2) | ZA200201668B (es) |
-
2000
- 2000-08-30 AR ARP000104515A patent/AR025443A1/es not_active Application Discontinuation
- 2000-08-31 CN CNA2005100992135A patent/CN1879632A/zh active Pending
- 2000-08-31 PE PE2000000895A patent/PE20010665A1/es not_active IP Right Cessation
- 2000-08-31 CO CO00065489A patent/CO5200771A1/es not_active Application Discontinuation
- 2000-10-18 EC EC2000003721A patent/ECSP003721A/es unknown
-
2002
- 2002-02-27 ZA ZA200201668A patent/ZA200201668B/xx unknown
-
2004
- 2004-03-05 AR ARP040100696A patent/AR043470A2/es not_active Application Discontinuation
-
2005
- 2005-05-25 ZA ZA200404083A patent/ZA200404083B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AR043470A2 (es) | 2005-07-27 |
ZA200404083B (en) | 2006-02-22 |
AR025443A1 (es) | 2002-11-27 |
CO5200771A1 (es) | 2002-09-27 |
PE20010665A1 (es) | 2001-06-19 |
ZA200201668B (en) | 2004-06-24 |
CN1879632A (zh) | 2006-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
YU14502A (sh) | Farmaceutska kombinacija etinilestradiola i drospirenona za primenu kao kontraceptivnog sredstva | |
NO327588B1 (no) | Farmasoytisk sammensetning og preparat omfattende etinylostradiol og drospirenon for anvendelse som antikonsepsjonsmiddel | |
UA41401C2 (uk) | Фармацевтичний контрацептивний комбінований препарат | |
BG66095B1 (bg) | Хидрофилен състав с контролирано освобождаване съдържащ прежелатинирано нишесте в препарат | |
HRP20090418T1 (en) | Pharmaceutical composition containing gestagens and/or estrogens and 5-methyl-(6s)-tetrahydrofolate | |
AR022589A1 (es) | UNA CÁPSULA QUE COMPRENDE UNA COMPOSICIoN FARMACÉUTICA ESPONTÁNEAMENTE DISPERSABLE PARA LA ADMINISTRACIoN ORAL, UNA COMPOSICIoN FARMACÉUTICA ESPONTÁNEAMENTE DISPERSABLE PARA LA ADMINISTRACIoN ORAL Y EL USO PARA LA PREPARACIoN DE UN MEDICAMENTO PARA EL TRATAMIENTO DEL CÁNCER | |
NZ307178A (en) | Medicament for contraception; contains two, separately packed, sequential hormonal components | |
KR970706004A (ko) | 호르몬 약물 및 에스트로겐 결핍을 치유하기 위한 그의 용도(novel hormonal medicaments and use thereof for correcting oestrogen deficiencies) | |
AR009113A1 (es) | UN PRODUCTO ANTICONCEPTIVO PARA DETENER LA OVULACIoN EN MUJERES DURANTE SU PERIODO DE ACTIVIDAD OVÁRICA | |
HRP20080394T3 (en) | Peroral solid dosage form for contraception comprising dienogest and ethinylestradiol | |
ECSP003721A (es) | Una composicion farmaceutica para ser usada como anticonceptivo | |
DOP2006000035A (es) | Preparación farmaceútica para la anticoncepción oral | |
RU2000115313A (ru) | Схемы приема гестаген-анти-гестагена | |
CA2248841A1 (en) | Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy | |
JO2213B1 (en) | A pharmaceutical composition for use as a contraceptive method | |
CO5280075A1 (es) | Drospirenona para terapia de reemplazo de hormonas | |
HRP20020666B1 (en) | Drospirenone for hormone replacement therapy | |
TH54054B (th) | สารผสมทางเภสัชกรรมสำหรับใช้เป็นยาคุมกำเนิด | |
UY29378A1 (es) | Preparación farmaceutica para la anticoncepción oral |